Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hexue Mingmu tablets
- Development stage
- Unknown
- Lead developer
- Grand Beilin Pharmaceutical
- Administration
- Oral
01
Overview
Hexue Mingmu tablets (also known as Hexue Mingmu Pian) is an approved traditional Chinese medicine (TCM) product developed and manufactured by Xi'an Beilin Pharmaceutical, a subsidiary of Grand Pharma (China Grand Enterprises). Formulated from three classic TCM prescriptions—Siwu Decoction (Siwu Tang), Erzhi Pills (Erzhi Wan), and Shengpuhuang Decoction (Shengpuhuang Tang)—the tablets contain a mixture of 18 herbal ingredients, including Pollen Typhae (Puhuang), Radix Salviae Miltiorrhizae (Danshen), Rehmanniae Radix (Dihuang), and Ecliptae Herba (Mohanlian). It is indicated for ophthalmic and blood-related conditions, specifically retinal hemorrhage, diabetic retinopathy, and wet age-related macular degeneration (wAMD). The formulation works by cooling the blood, promoting hemostasis, nourishing yin, removing blood stasis, and improving liver and eye health.
- Brand names
- Beilin
- Other names
- Hexue Mingmu Pian和血明目片
02
Targets
ALDH2 (Mitochondrial Aldehyde Dehydrogenase)ApoD (Apolipoprotein D)CD300A (CD300A molecule)CD36 (CD36 antigen)CNR1 (Cannabinoid receptor 1)CYCS (Cytochrome c)AST (Glutamate oxaloacetate transaminase 1)IL-6 (Interleukin 6)PECAM1 (PECAM-1)PTGER2 (Prostaglandin E2 receptor EP2)VEGFA (Vascular endothelial growth factor A)VEGFB (Vascular endothelial growth factor B)
Beyond the preview
Go deeper on Hexue Mingmu tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hexue Mingmu tablets.